![NanoBio First - Funding Program for World-Leading Innovative R&D on Science and Technology_[Development of Innovative Diagnostic and Therapeutic Systems Based on Nanobiotechnology]](../common/img/head_title.gif)
Core Researcher
Kazunori KATAOKA ／ Kazunori KATAOKA
Sub-project II Leader
Development of Supramolecular Nanocarriers for Drug and Gene Delivery
Nanobiotechnology- and nanobioengineering-based medicine that is aimed to control the cellular function and fate in a desirable manner, should be the key to success in the treatment of intractable diseases and tissue engineering. Thus, there is recently a strong impetus to the development of funcitonal nanodevices that promote cell differentiation at the desired site or deliver therapeutic agents such as drugs and genes to the targeted cells. We develop supramolecular "smart" nanocarriers including polymeric micelles, polymeric vesicles and multi-layered nanoparticles, through the self-assembly of artificial and natural materials, and carry out the nanocarrier-mediated therapy by facilitating the translation of basic achievements into clinical applications. Our goal is to produce revolutionary medical nanodevices, thereby contributing to realization of the futuristic medical system.
| Affiliation | Departments of Materials Engineering, Graduate Schools of Engineering, / Division of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine,The University of Tokyo |
| Specialty | Drug Delivery System, Biomaterials |
| Awards and Honors |
|
| Professional Experience |
|
| URL | http://www.bmw.t.u-tokyo.ac.jp/ |
| TEL | 03-5841-7138 |
| FAX | 03-5841-7139 |
 |
|
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656 Japan |